Wired focuses on GLP-1 patient fallout

Kudos to Wired for its piece, “A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating.” It’s all about how patients who have gotten used to the price and availability of compounded tirzepatide are now facing a double whammy of not being able to get the commercial version, and even if they can, the sticker shock hits hard.

One of the better articles we've seen lately comes from USA Today, explaining what is likely to...

APC CEO Scott Brunner was a guest on “On The Pen” — a YouTube channel dedicated to all things...

CNN’s Meg Tirrell gets to the heart of the matter in “The end of a shortage of popular weight-loss...

Wired focuses on GLP-1 patient fallout

Related posts

USA Today’s balanced article on the future of GLP-1s

Video appearance: APC talks the legal issues

CNN gets it spot on